Breaking News
Get 55% Off 0
🍎 🍕 Less apples, more pizza 🤔 Have you seen Buffett’s portfolio recently?
Explore for Free
Close

Jpmorgan Funds - Thematics - Genetic Therapies A (acc) - Usd (0P0001INWK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
93.860 +1.220    +1.32%
22/11 - Closed. Currency in USD
Type:  Fund
Market:  Luxembourg
ISIN:  LU2050612402 
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 470.84M
JPMorgan Funds - Thematics - Genetic Therapies A ( 93.860 +1.220 +1.32%

Jpmorgan Funds - Thematics - Genetic Therapies A (acc) - Usd Overview

 
Find basic information about the Jpmorgan Funds - Thematics - Genetic Therapies A (acc) - Usd mutual fund such as total assets, risk rating, Min. investment, market cap and category. Learn about the fund's agencies rating and risk rating, transparent information about the fund's management personal, policies of invested allocation and diversification, past performance. In addition we provide you related news, analysis tools, interactive charts and analysis articles. You may add 0P0001INWK MF to your portfolio and watchlist to keep track with the fund's performance and users commentary. (ISIN: LU2050612402)
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Rating
1-Year Change1.97%
Prev. Close92.64
Risk Rating
TTM Yield0%
ROE - 2.13%
IssuerN/A
Turnover18.26%
ROA - 7.82%
Inception DateOct 24, 2019
Total Assets470.84M
Expenses0.93%
Min. Investment35,000
Market Cap12.17B
CategorySector Equity Biotechnology
What is your sentiment on JPMorgan Funds - Thematics - Genetic Therapies A (?
or
Market is currently closed. Voting is open during market hours.

Performance

Create Alert
Add to Watchlist
Add to/Remove from Watchlist  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

YTD 3M 1Y 3Y 5Y 10Y
Growth of 1000 965 1083 965 593 - -
Fund Return -3.47% 8.34% -3.47% -15.97% - -
Place in category 168 164 168 131 - -
% in Category 80 74 80 84 - -

Top Equity Funds by JPMorgan Asset Management (Europe) S.à r.l.

  Name Rating Total Assets YTD% 3Y% 10Y%
  JPI Global Income Fund A div USD he 17.93B 9.78 2.47 4.18
  JPI Global Income Fund A mth USD he 17.93B 9.75 2.44 4.16
  JPI Global Income Fund C acc USD he 17.93B 10.32 3.13 4.86
  JPI Global Income Fund C dist USD h 17.93B 10.31 3.12 4.85
  JPI Global Income Fund C mth USD he 17.93B 10.32 3.13 4.85

Top Funds for Sector Equity Biotechnology Category

  Name Rating Total Assets YTD% 3Y% 10Y%
  Franklin Biotech Discovery Nacc 101.15M 4.88 -4.60 3.64
  Candriam Equities Biotech C USD Cap 1.41B 11.83 4.94 6.48
  LU0133359157 1.41B 11.48 4.52 6.01
  Equities L Biotechnology Class I US 1.41B 12.01 4.82 6.85
  Equities L Biotechnology Class R US 1.41B 12.65 5.83 7.34

Top Holdings

Name ISIN Weight % Last Change %
  Alnylam US02043Q1076 3.31 244.89 -0.77%
  Vertex US92532F1003 3.18 450.97 +0.13%
  Amgen US0311621009 3.12 294.53 +1.60%
  Novartis CH0012005267 3.08 93.68 +2.32%
  Biomarin Pharma US09061G1013 3.04 64.26 +1.28%

Technical Summary

Type Daily Weekly Monthly
Moving Averages Sell Strong Sell Strong Sell
Technical Indicators Strong Sell Strong Sell Strong Sell
Summary Strong Sell Strong Sell Strong Sell
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P0001INWK Comments

Write your thoughts about Jpmorgan Funds - Thematics - Genetic Therapies A (acc) - Usd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email